Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$651M |
| 2 |
Charter Communications
CHTR
|
$643M |
| 3 |
Parker-Hannifin
PH
|
$606M |
| 4 |
Goldman Sachs
GS
|
$534M |
| 5 |
FedEx
FDX
|
$376M |
Top Sells
| 1 |
Biogen
BIIB
|
$701M |
| 2 |
American Tower
AMT
|
$665M |
| 3 |
Nike
NKE
|
$595M |
| 4 |
AGN
Allergan plc
AGN
|
$569M |
| 5 |
McDonald's
MCD
|
$556M |
Sector Composition
| 1 | Technology | 18.72% |
| 2 | Consumer Discretionary | 17.48% |
| 3 | Healthcare | 13.38% |
| 4 | Communication Services | 12.13% |
| 5 | Financials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Agnico Eagle Mines
AEM
$77.4B
| $40.1M | 0.04% |
955,692
-68,870
| -7% | -$2.89M |
|
302
Thermo Fisher Scientific
TMO
$183B
| $40M | 0.04% |
283,314
-6,388
| -2% | -$901K |
|
303
Treehouse Foods
THS
$893M
| $39.8M | 0.04% |
+551,109
| New | +$39.8M |
|
304
Acadia Pharmaceuticals
ACAD
$4.3B
| $39.6M | 0.04% |
+1,372,679
| New | +$39.6M |
|
305
Benchmark Electronics
BHE
$1.44B
| $39.5M | 0.04% |
1,296,645
+65,636
| +5% | +$2M |
|
|
GNMK
306
DELISTED
GenMark Diagnostics, Inc
GNMK
| $39.4M | 0.04% |
3,222,716
+342,213
| +12% | +$4.19M |
|
307
Devon Energy
DVN
$21.8B
| $39.2M | 0.04% |
859,236
-316,596
| -27% | -$14.5M |
|
308
Boston Scientific
BSX
$160B
| $38.7M | 0.04% |
+1,788,316
| New | +$38.7M |
|
|
DBD
309
DELISTED
Diebold Nixdorf Incorporated
DBD
| $38.5M | 0.04% |
1,532,529
-460,740
| -23% | -$11.6M |
|
|
NFX
310
DELISTED
Newfield Exploration
NFX
| $38.3M | 0.04% |
945,926
-1,233,825
| -57% | -$50M |
|
311
General Dynamics
GD
$86.6B
| $38.1M | 0.04% |
220,606
+198,950
| +919% | +$34.4M |
|
312
Darling Ingredients
DAR
$4.91B
| $38M | 0.04% |
2,947,187
+74,373
| +3% | +$960K |
|
|
VWR
313
DELISTED
VWR Corporation
VWR
| $37.3M | 0.04% |
1,489,896
+457,622
| +44% | +$11.5M |
|
|
BMS
314
DELISTED
Bemis
BMS
| $37.2M | 0.04% |
778,915
-419,436
| -35% | -$20.1M |
|
315
Target
TGT
$41.7B
| $37.1M | 0.04% |
514,104
-48,458
| -9% | -$3.5M |
|
|
BRCD
316
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $36.6M | 0.04% |
2,927,443
-3,080,175
| -51% | -$38.5M |
|
317
Criteo
CRTO
$1.24B
| $36.2M | 0.04% |
880,233
+22,038
| +3% | +$905K |
|
|
DNKN
318
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $36.1M | 0.04% |
688,024
+167,030
| +32% | +$8.76M |
|
319
Texas Roadhouse
TXRH
$11.1B
| $35.8M | 0.04% |
742,841
-20,392
| -3% | -$984K |
|
320
CoreCivic
CXW
$2.08B
| $35.5M | 0.04% |
+1,451,263
| New | +$35.5M |
|
321
Ultragenyx Pharmaceutical
RARE
$3.04B
| $35.2M | 0.04% |
500,290
+1,844
| +0.4% | +$130K |
|
322
Honeywell
HON
$136B
| $35.1M | 0.04% |
315,892
+307,552
| +3,688% | +$34.1M |
|
|
NXTM
323
DELISTED
NxStage Medical Inc.
NXTM
| $34.8M | 0.04% |
1,328,173
+21,686
| +2% | +$568K |
|
324
Owens Corning
OC
$13B
| $34.7M | 0.04% |
672,913
-275,926
| -29% | -$14.2M |
|
325
Park Hotels & Resorts
PK
$2.38B
| $34.6M | 0.04% |
+1,278,888
| New | +$34.6M |
|